Eurazeo delays fundraising by up to nine months
Eurazeo has published an update on its portfolio and investment activities in the wake of the Coronavirus outbreak, including the fact it is expecting a delay of up to nine months to its fundraising activity.
The GP's Eurazeo Growth Fund III held an interim close on €155m in December 2019 and was previously expected to hold another close in Q1 2020 and a final close by the end of 2020.
The GP, at its annual shareholders' meeting on 30 April, said there will be little investment and divestment activity throughout the first half of 2020.
However, it said it was possible that more acquisition opportunities might arise during the second six months of the year, or in 2021, and that it will seize these when they come up.
The PE house also announced measures it was taking to tackle the coronavirus outbreak. These include the GP cancelling 2019 dividend payments to its shareholders, freezing recruitment, and drawing €400m from its €1.5bn syndicated credit facility.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









